A theme focused on building and expanding the capability to provide a broad range of nonclinical safety testing services, including carcinogenicity studies in addition to pharmacological efficacy studies, through the acquisition of the safety testing business from 安評センター. This includes expanding orders and rolling out high-value-added testing services after the business acquisition.